William A. Curran

Davis Polk advised the underwriters in connection with the $575 million initial public offering of 57,500,000 units of Vy Global Growth, which includes 7,500,000 units from the full…

Davis Polk advised Coloplast A/S in connection with its strategic equity investment in Francis Medical, Inc.Coloplast A/S is a Danish medical device company that develops products and…

Davis Polk is advising an ad hoc group of noteholders (the “Ad Hoc Group”) in connection with a restructuring of Superior Energy Services, Inc. and its subsidiaries (collectively, the …

Davis Polk is advising CrowdStrike Holdings, Inc. in connection with its acquisition of Preempt Security, Inc., a leading provider of Zero Trust and conditional access technology for real…

Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately $805 million. The…

Davis Polk advised Arcos Dorados Holdings Inc. in connection with the offering of $150 million aggregate principal amount of its 5.875% senior notes due 2027. The notes were sold in an…

Davis Polk advised the underwriter in connection with the initial public offering of 30,000,000 units of Broadstone Acquisition Corp., for aggregate proceeds of $300 million. Each unit…

Davis Polk advised the underwriters in connection with the initial public offering of 30,000,000 units of Prime Impact Acquisition I, for aggregate proceeds of $300 million. Each unit…

Davis Polk is advising San Juan Offshore LLC (“San Juan”) on its proposed acquisition of Arena Energy LP (“Arena”) pursuant to a prepackaged chapter 11 plan (the “Plan”) for Arena. On…

Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and future success-based milestone payments. The transaction is…